Page last updated: 2024-08-23

lovastatin and Angor Pectoris

lovastatin has been researched along with Angor Pectoris in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (80.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reynolds, T; Wierzbicki, A1
Shepherd, J1
Huttunen, J1
Carotenuto, A; Carreras, G; de Divitiis, M; de Divitiis, O; Di Somma, S; Galderisi, M; Greco, V; Iannuzzo, G; Liguori, V; Montefusco, S; Rubba, P1
Auer, J; Eber, B1
Alexander, S; Bilodeau, T; Carlson, W; Clark, M; Johnstone, M; Karam, C; Kinlay, S; Lloyd-Jones, DM; Orav, J; Ridker, PM; Rifai, N; Rubenstein, J; Stone, PH; Timms, T1
Kukharchuk, V; Martinov, A; Pomerantsev, E; Shabalkin, B; Titov, V; Yurenev, A; Zhukova, I1
Cohn, PF1

Reviews

2 review(s) available for lovastatin and Angor Pectoris

ArticleYear
Statin therapy in clinical practice: new developments.
    Current opinion in lipidology, 1995, Volume: 6, Issue:5

    Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Enzyme Inhibitors; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Middle Aged; Myocardial Infarction; Simvastatin

1995
A clinical focus on statins.
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:3

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Down-Regulation; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Multicenter Studies as Topic; Myocardial Infarction; Practice Guidelines as Topic; Pravastatin; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Simvastatin

2001

Trials

5 trial(s) available for lovastatin and Angor Pectoris

ArticleYear
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
    Lancet (London, England), 1994, Nov-19, Volume: 344, Issue:8934

    Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors; Simvastatin; Survival Analysis

1994
Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction.
    The American journal of cardiology, 1993, Feb-15, Volume: 71, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Double-Blind Method; Ethics, Medical; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Scandinavian and Nordic Countries; Simvastatin; Time Factors

1993
Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia.
    The American journal of cardiology, 1996, Oct-01, Volume: 78, Issue:7

    Topics: Analysis of Variance; Angina Pectoris; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Electrocardiography; Exercise Test; Forearm; Humans; Hypercholesterolemia; Lovastatin; Middle Aged; Regional Blood Flow; Simvastatin; Single-Blind Method

1996
Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia.
    The American journal of cardiology, 2002, May-15, Volume: 89, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina Pectoris; Atorvastatin; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Heptanoic Acids; Humans; Hypolipidemic Agents; Lovastatin; Middle Aged; Myocardial Ischemia; Pyrroles; Time Factors; Treatment Outcome; Triglycerides

2002
Long-term experience with lovastatin treatment in patients with coronary heart disease and hyperlipoproteinaemia type II.
    European heart journal, 1992, Volume: 13 Suppl B

    Topics: Adult; Aged; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Test; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Middle Aged

1992

Other Studies

3 other study(ies) available for lovastatin and Angor Pectoris

ArticleYear
Treatment of myocardial infarction and angina. Advice on reducing cholesterol should be included.
    BMJ (Clinical research ed.), 1995, Feb-18, Volume: 310, Issue:6977

    Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Humans; Lovastatin; Myocardial Infarction; Simvastatin

1995
[The cholesterol hypothesis has been proved true at last].
    Duodecim; laaketieteellinen aikakauskirja, 1995, Volume: 111, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Cholesterol; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Simvastatin

1995
Silent myocardial ischemia--classification and management.
    Hospital practice (Office ed.), 1990, Feb-28, Volume: 25, Issue:2A

    Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Nifedipine; Risk Factors

1990